These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 3838691

  • 21. Effect of cholecystokinin octapeptide and ceruletide on release of acetylcholine from cerebral cortex of the rat in vivo.
    Magnani M, Mantovani P, Pepeu G.
    Neuropharmacology; 1984 Nov; 23(11):1305-9. PubMed ID: 6098846
    [Abstract] [Full Text] [Related]

  • 22. Reversal of spinal cord non-opiate analgesia by conditioned anti-analgesia in the rat.
    Watkins LR, McGorry M, Schwartz B, Sisk D, Wiertelak EP, Maier SF.
    Pain; 1997 Jul; 71(3):237-47. PubMed ID: 9231866
    [Abstract] [Full Text] [Related]

  • 23. Cholecystokinin and its antagonist lorglumide respectively attenuate and facilitate morphine-induced inhibition of C-fiber evoked discharges of dorsal horn nociceptive neurons.
    Kellstein DE, Price DD, Mayer DJ.
    Brain Res; 1991 Feb 01; 540(1-2):302-6. PubMed ID: 2054623
    [Abstract] [Full Text] [Related]

  • 24. Involvement of spinal opioid systems in footshock-induced analgesia: antagonism by naloxone is possible only before induction of analgesia.
    Watkins LR, Mayer DJ.
    Brain Res; 1982 Jun 24; 242(2):309-26. PubMed ID: 6896839
    [Abstract] [Full Text] [Related]

  • 25. Delta opiate receptors mediate tail-shock induced antinociception at supraspinal levels.
    Watkins LR, Wiertelak EP, Maier SF.
    Brain Res; 1992 Jun 05; 582(1):10-21. PubMed ID: 1323369
    [Abstract] [Full Text] [Related]

  • 26. Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammation.
    Stanfa LC, Dickenson AH.
    Br J Pharmacol; 1993 Apr 05; 108(4):967-73. PubMed ID: 8485635
    [Abstract] [Full Text] [Related]

  • 27. Dissociation of tolerance and dependence to morphine: a possible role for cholecystokinin.
    Panerai AE, Rovati LC, Cocco E, Sacerdote P, Mantegazza P.
    Brain Res; 1987 Apr 28; 410(1):52-60. PubMed ID: 3580899
    [Abstract] [Full Text] [Related]

  • 28. Proglumide prevents and curtails acute tolerance to morphine in rats.
    Tang J, Chou J, Iadarola M, Yang HY, Costa E.
    Neuropharmacology; 1984 Jun 28; 23(6):715-8. PubMed ID: 6462377
    [Abstract] [Full Text] [Related]

  • 29. Opiate vs non-opiate footshock-induced analgesia (FSIA): the body region shocked is a critical factor.
    Watkins LR, Cobelli DA, Faris P, Aceto MD, Mayer DJ.
    Brain Res; 1982 Jun 24; 242(2):299-308. PubMed ID: 7116137
    [Abstract] [Full Text] [Related]

  • 30. Endogenous opiates and stress ulceration.
    Morley JE, Levine AS, Silvis SE.
    Life Sci; 1982 Aug 16; 31(7):693-9. PubMed ID: 7132574
    [Abstract] [Full Text] [Related]

  • 31. Electrophysiological studies on the specificity of the cholecystokinin antagonist proglumide.
    Chiodo LA, Freeman AS, Bunney BS.
    Brain Res; 1987 May 05; 410(2):205-11. PubMed ID: 3036308
    [Abstract] [Full Text] [Related]

  • 32. The neurochemical basis of footshock analgesia: the role of spinal cord serotonin and norepinephrine.
    Watkins LR, Johannessen JN, Kinscheck IB, Mayer DJ.
    Brain Res; 1984 Jan 02; 290(1):107-17. PubMed ID: 6692126
    [Abstract] [Full Text] [Related]

  • 33. Interactions of cholecystokinin, beta-endorphin, and their antagonists on passive avoidance behavior in rats.
    Itoh S, Katsuura G, Takashima A.
    Can J Physiol Pharmacol; 1987 Nov 02; 65(11):2260-4. PubMed ID: 2966663
    [Abstract] [Full Text] [Related]

  • 34. Opiate and non-opiate analgesia induced by inescapable tail-shock: effects of dorsolateral funiculus lesions and decerebration.
    Watkins LR, Drugan R, Hyson RL, Moye TB, Ryan SM, Mayer DJ, Maier SF.
    Brain Res; 1984 Jan 23; 291(2):325-36. PubMed ID: 6697193
    [Abstract] [Full Text] [Related]

  • 35. Rats with decreased brain cholecystokinin levels show increased responsiveness to peripheral electrical stimulation-induced analgesia.
    Zhang LX, Li XL, Wang L, Han JS.
    Brain Res; 1997 Jan 16; 745(1-2):158-64. PubMed ID: 9037405
    [Abstract] [Full Text] [Related]

  • 36. Spinal cord mediation of the opioid analgesia of pregnancy.
    Sander HW, Gintzler AR.
    Brain Res; 1987 Apr 07; 408(1-2):389-93. PubMed ID: 3594229
    [Abstract] [Full Text] [Related]

  • 37. Proglumide, a cholecystokinin antagonist, increases gastric emptying in rats.
    Shillabeer G, Davison JS.
    Am J Physiol; 1987 Feb 07; 252(2 Pt 2):R353-60. PubMed ID: 3812772
    [Abstract] [Full Text] [Related]

  • 38. Classical conditioning of front paw and hind paw footshock induced analgesia (FSIA): naloxone reversibility and descending pathways.
    Watkins LR, Cobelli DA, Mayer DJ.
    Brain Res; 1982 Jul 08; 243(1):119-32. PubMed ID: 7116148
    [Abstract] [Full Text] [Related]

  • 39. The neural basis of footshock analgesia: the role of specific ventral medullary nuclei.
    Watkins LR, Young EG, Kinscheck IB, Mayer DJ.
    Brain Res; 1983 Oct 16; 276(2):305-15. PubMed ID: 6627011
    [Abstract] [Full Text] [Related]

  • 40. Differential modulation of alpha 2-adrenergic and opioid spinal antinociception by cholecystokinin and cholecystokinin antagonists in the rat dorsal horn: an electrophysiological study.
    Sullivan AF, Hewett K, Dickenson AH.
    Brain Res; 1994 Oct 31; 662(1-2):141-7. PubMed ID: 7859067
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.